Edition:
United States

Biocon Ltd (BION.NS)

BION.NS on National Stock Exchange of India

1,132.45INR
27 Mar 2017
Change (% chg)

-- (--)
Prev Close
Rs1,132.45
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
707,427
52-wk High
Rs1,152.15
52-wk Low
Rs462.65

Latest Key Developments (Source: Significant Developments)

Biocon reaffrims guidance of $200 mln in revenue from biosimilars in FY19
Tuesday, 14 Mar 2017 06:04am EDT 

Biocon Ltd :Says reaffrims guidance of US $200 million in revenue from biosimilars in FY19.  Full Article

Biocon Ltd says USFDA accepts BLA for Mylan & co's proposed biosimilar trastuzumab
Wednesday, 11 Jan 2017 08:11am EST 

Biocon Ltd : Says U.S. FDA accepts Biologics License Application (BLA) for Mylan and Biocon's proposed biosimilar trastuzumab . Says anticipated FDA goal date set under BSUFA is Sept 3, 2017 . Says product is a proposed biosimilar to branded trastuzumab, which is indicated to treat certain HER2-positive breast cancers .Says Maylan and co's proposed biosimiar trastuzumab is also under review by EMA.  Full Article

Biocon Ltd says co and Mylan's proposed biosimilar accepted for review by EMA
Thursday, 21 Jul 2016 10:08am EDT 

Biocon Ltd : Mylan & Biocon announce regulatory submission for proposed biosimilar Pegfilgrastim accepted for review by European Medicines Agency . Co has exclusive commercialization rights with Mylan for proposed biosimilar in US, Canada, Japan, Australia, New Zealand, European Union countries . Biocon has co-exclusive commercialization rights with Mylan for the product in rest of the world .  Full Article

India's Biocon Ltd June-qtr consol profit up about 35 pct
Thursday, 21 Jul 2016 09:35am EDT 

Biocon Ltd : India's Biocon Ltd says June-quarter consol net profit 1.67 billion rupees . Says June-quarter consol net sales 9.72 billion rupees . Consensus forecast for June-quarter net profit was 1.18 billion rupees . Says consol net profit in June-quarter last year was 1.24 billion rupees as per Ind-AS; consol net sales was 7.58 billion rupees .  Full Article

Biocon Ltd lnaugurates world class devices facility & Introduces Basalog One
Tuesday, 15 Sep 2015 09:17am EDT 

Biocon Ltd:Says inaugurated a world class facility for manufacturing new generaion patient-friendly devices for its insulines portfolio.  Full Article

Biocon Ltd booked for dumping waste - Deccan Herald
Tuesday, 7 Jul 2015 08:00pm EDT 

Biocon Ltd:Says BBMP on July 6 lodged a police complaint against Biocon for dumping chemical waste at the Terra Firma waste-processing unit near Doddaballapur in Bengaluru Rural district - Deccan Herald.Says Biocon maintains the waste is non-hazardous.Says Villagers living around the Terra Firma unit had protested against the dumping of waste but relented after district in-charge minister Ramalinga Reddy assured action against Biocon.  Full Article

Biocon Ltd announces payment date of interim dividend
Monday, 20 Apr 2015 02:37am EDT 

Biocon Ltd:Says they have informed on the declaration of interim dividend at a rate of 100 pct i.e. (5 Indian rupee per share) for the financial year 2014-15 and fixed the record date as April 10.Says it has now informed BSE that the company has paid the interim dividend to eligible shareholders on April 15.  Full Article

Biocon Ltd gets Mexican approval for its insulin Glargine-Business Standard
Thursday, 9 Apr 2015 09:58am EDT 

Biocon Ltd:Received approval for its Insulin Glargine by Cofepris, the Mexican health authority, through its partner PiSA Farmaceutica-Business Standard.  Full Article

More From Around the Web

BRIEF-Biocon reaffrims guidance of $200 mln in revenue from biosimilars in FY19

* Says reaffrims guidance of US $200 million in revenue from biosimilars in FY19 Source text - (http://bit.ly/2nztIMx) Further company coverage:

No consensus analysis data available.